Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-138282
Filing Date
2021-04-29
Accepted
2021-04-29 07:07:00
Documents
5
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d123394ddef14a.htm DEF 14A 490716
2 GRAPHIC g123394dsp001.jpg GRAPHIC 120007
3 GRAPHIC g123394dsp002.jpg GRAPHIC 344275
4 GRAPHIC g123394g15u17.jpg GRAPHIC 20571
5 GRAPHIC g123394g68p67.jpg GRAPHIC 20035
  Complete submission text file 0001193125-21-138282.txt   1183257
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37773 | Film No.: 21867033
SIC: 2834 Pharmaceutical Preparations